The Carlyle Group Inc. CG | NASDAQ

$40.47 $1.31 | 3.35%

Next Earnings: May 08, 2025

Company Overview:

Market Cap: $14.60B
PE Ratio: 14.61
52-Week Range: $33.02 - $57.50
Dividend Yield (FWD): 3.58% ($1.40)

10 Year Performance Metrics:

Total Return (with DRIP): 113.70% (7.89% / yr)
Total Return (no DRIP): 67.70% (5.31% / yr)
Share Price: 24.36%
Dividend Increase: 6.06
CG 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

CG Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
CG Dividend CAGR:1Y: 0.00%2Y: 3.77%5Y: 6.96%10Y: -14.15%
Share Price
CG Price CAGR:1Y: -4.42%2Y: 13.39%5Y: 12.04%10Y: 2.42%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

CG Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - CG
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - CG
14-Day FREE Trial Get Full Access Now!

CG Earnings, Revenue, Cash & Debt, Shares Outstaning:

CG - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
CG - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CG - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CG - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
CG - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
CG - Cash & Debt
14-Day FREE Trial Get Full Access Now!
CG - Revenue
14-Day FREE Trial Get Full Access Now!
CG Revenue CAGR:1Y: -16.27%2Y: 9.16%5Y: 17.58%10Y: 14.61%
CG - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
CG EPS CAGR:1Y: 129.69%2Y: 27.62%5Y: 91.64%10Y: 9.50%
CG - Net Income
14-Day FREE Trial Get Full Access Now!
CG Net Income CAGR:1Y: 130.48%2Y: 28.76%5Y: 93.90%10Y: 29.34%
CG - EBITDA
14-Day FREE Trial Get Full Access Now!
CG EBITDA CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
CG - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
CG Free Cash Flow CAGR:1Y: -232.92%2Y: 66.80%5Y: -8.00%10Y: N/A
CG - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
CG Free Cash Flow / Share CAGR:1Y: -233.75%2Y: 67.85%5Y: -26.38%10Y: N/A
CG - Gross Profit
14-Day FREE Trial Get Full Access Now!
CG Gross Profit CAGR:1Y: 299.15%2Y: 47.64%5Y: 17.58%10Y: 5.77%
CG - Expenses
14-Day FREE Trial Get Full Access Now!
CG Expenses CAGR:1Y: 57.06%2Y: 30.83%5Y: 20.99%10Y: 6.22%
CG - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
CG Shares Outstanding CAGR:1Y: 2.00%2Y: 0.19%5Y: 1.18%10Y: 2.13%
CG - Share Buybacks
14-Day FREE Trial Get Full Access Now!
CG Share Buybacks CAGR:1Y: 37,800.00%2Y: 39.95%5Y: 0.00%10Y: 0.00%
CG - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
CG Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
CG - Dividends
14-Day FREE Trial Get Full Access Now!
CG Dividend CAGR:1Y: 0.00%2Y: 3.77%5Y: 6.96%10Y: -14.15%
CG - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
CG Revenue CAGR:1Y: -16.27%2Y: 9.16%5Y: 17.58%10Y: 14.61%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CG - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CG Actual Revenue CAGR:1Y: -16.27%2Y: 9.16%5Y: 17.58%10Y: 14.61%
CG - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CG Actual EPS CAGR:1Y: 129.69%2Y: 27.62%5Y: 91.64%10Y: 9.50%
CG - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CG Actual Net Income CAGR:1Y: 130.48%2Y: 28.76%5Y: 93.90%10Y: 29.34%
CG - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CG Actual EBITDA CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%

Ratios, Profit Margins & Return on Capital:

CG - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
CG Net Profit Margin CAGR:1Y: 136.40%2Y: 17.96%5Y: 67.79%10Y: 12.85%
CG - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
CG Gross Profit Margin CAGR:1Y: 337.87%2Y: 46.66%5Y: 0.00%10Y: -7.71%
CG - Price to Earnings
14-Day FREE Trial Get Full Access Now!
CG - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
CG - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
CG - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

CG Dividends Info:

Annual Dividend: $1.40
Forward Yield: 3.46%
Ex-Dividend Date: 2025-02-21
Lifetime Dividens / Share: $18.74

CG Dividend History: Dates, Payments & Yield list

Below is a schedule of all CG dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
02/21/202502/28/2025$0.3502.81%2.81%$49.86
11/18/202411/25/2024$0.3502.75%2.75%$50.86
08/16/202408/26/2024$0.3503.41%3.41%$41.11
05/13/202405/21/2024$0.3503.36%3.36%$41.72
02/22/202403/01/2024$0.3503.11%3.11%$44.99
11/20/202311/29/2023$0.3504.31%4.39%$31.88
08/14/202308/23/2023$0.3504.3%4.46%$31.37
05/15/202305/23/2023$0.3504.95%5.23%$26.78
02/21/202303/01/2023$0.3253.82%3.82%$34.05
11/17/202211/25/2022$0.3254.28%4.55%$28.60
08/08/202208/16/2022$0.3253.26%3.68%$35.29
05/09/202205/17/2022$0.3253.03%3.66%$35.52
02/14/202202/23/2022$0.2502.14%2.14%$46.77
11/08/202111/17/2021$0.2501.7%1.7%$58.70
08/09/202108/17/2021$0.2502.12%2.12%$47.21
05/10/202105/19/2021$0.2502.25%2.25%$44.51
02/12/202102/23/2021$0.2502.69%2.69%$37.16
11/09/202011/17/2020$0.2503.62%3.62%$27.66
08/10/202008/18/2020$0.2503.9%3.68%$27.21
05/11/202005/19/2020$0.2505.04%4.07%$24.58
02/14/202002/25/2020$0.2503.67%3.11%$32.13
11/08/201911/19/2019$0.3104.97%4.53%$27.39
08/09/201908/19/2019$0.4306.53%7.64%$22.50
05/10/201905/21/2019$0.1906.11%3.69%$20.62
02/15/201902/26/2019$0.4307.26%9.32%$18.46
11/09/201811/20/2018$0.4206.22%8.42%$19.95
08/10/201808/17/2018$0.2205.87%3.74%$23.50
05/10/201805/17/2018$0.2707.26%4.97%$21.75
02/16/201802/27/2018$0.3306.05%5.67%$23.30
11/09/201711/16/2017$0.5605.77%10.42%$21.50
08/10/201708/21/2017$0.4205.78%8.24%$20.40
05/11/201705/22/2017$0.1007.7%2.22%$18.05
02/16/201702/28/2017$0.1609.69%4%$16.00
11/04/201611/16/2016$0.50011.28%13.42%$14.90
08/11/201608/24/2016$0.63010.83%15.69%$16.06
05/12/201605/25/2016$0.26012.6%6.55%$15.87
02/19/201603/02/2016$0.29013.75%7.71%$15.05
11/12/201511/24/2015$0.56019.11%12.63%$17.74
08/17/201508/27/2015$0.89012.65%15.07%$23.63
05/13/201505/22/2015$0.3307.61%4.45%$29.68
02/19/201503/06/2015$1.6107.74%23.83%$27.02
11/06/201411/21/2014$0.1606.65%2.26%$28.26
08/07/201408/22/2014$0.1606.15%2.09%$30.59
05/12/201405/22/2014$0.1606.03%2.05%$31.19
02/27/201403/11/2014$1.4005.21%15.53%$36.06
11/14/201311/27/2013$0.1604.17%2.01%$31.86
08/15/201308/30/2013$0.1605.12%2.46%$25.97
05/16/201305/31/2013$0.1604.27%2.13%$29.99
02/28/201303/13/2013$0.8503.54%10.73%$31.68
11/15/201211/30/2012$0.1601.06%2.5%$25.56
08/16/201208/31/2012$0.1100.44%1.76%$24.99

Projected Future Returns & Dividends for CG

Based on past 10-year performance, here are CG growth metrics:

Share price CAGR of +2.42%
Dividend CAGR of -14.17%

Using CG CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

CG (DRIP)CG - No DRIP
Current Price$39.16$39.16
Start Shares255.36255.36
Start Value$10,000$10,000
  
After 10 years:
Final Share Count306.49255.36
Dividends Payment$0.08$0.08
Annual Dividends$93$78
Yield on cost0.93%0.78%
Share Price$48.55$48.55
Total Dividends$2,168$1,975
Final Value$14,880$14,373

Estimated Future Value + Dividends - CG

NOTE: Above numbers are our estimate based on CG's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

The Carlyle Group Inc. (CG) had its IPO on 2012-05-03, and is trader on NASDAQ stock exchange.

The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $1 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $10 million and $500 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. It typically holds its investments for three to five years. Within automotive and transportation sectors, the firm seeks to hold its investments in for four to six years. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices in 21 countries across 5 continents (North America, South America, Asia, Australia and Europe).

CG website: https://www.carlyle.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial